Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: 1U54 CA232561-01A1
NCI NIH HHS
Grant: R01 CA160461
NCI NIH HHS
Grant: U54 CA232561
National Institutes of Health
Grant: 3U54CA232561-01A1S5
Diversity Supplement: Hernandez-Aguirre- Cripe U54
Pediatric Cancer Research Foundation
US Department of Defense
New York Medical College
Children’s Cancer Foundation
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords